(image credit: brinknews.com)
"With fines of up to 20 million euros ($23 million) or four percent of global annual turnover—which, for Fortune 100 companies, could reach billions of euros—and new..
(image credit: prosci.com)
Changes ultimately come to life through the individuals who have to do their jobs differently as a result of a project or initiative. Whether the project involves a..
So you want to take advantage of hosted SAS for managing clinical trial data, but not sure how to go about the transition?
There are many reasons life sciences companies are turning to cloud-based..
Life Sciences News - Major research funders and international NGOs to implement WHO standards on reporting clinical trial results
18 MAY 2017 | GENEVA – Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials..
DATE OF OCCURRENCE: MAR 25, 2017
Life Sciences News - d-Wise to Unveil its New Clinical Acceleration Platform at BIO-IT World - Held at Seaport World Trade Center, Boston, May 23-25.
This regulatory compliant ‘pay by month/pay-by-study’ cloud-based offering will offer biotech, pharma & CROs unprecedented agility and rapid deployment through unprecedented access to SAS® and..
d-Wise, a leading global technology consultancy and clinical software provider, has been named "SAS US Regional Partner of the Year 2017." The award was presented at SAS Global Forum 2017 in Orlando,..
Life Sciences News - How to deploy a secure, compliant, cloud-based SAS clinical computing platform…in 24 hours!
April 20th, 2017 | 11 am to 12 pm EDT
This webinar will introduce attendees to the concept of moving their statistical computing resources to a secure, scalable clinical cloud environment and the..
Life Sciences News - Policy 0070 Under the Microscope: The Trade-off Between Clinical Trial Transparency and the Risk of Revealing Patient Identities
The last few months have seen a battle build between the pharma industry and the EMA, following the issue of new guidance promoting greater transparency in clinical trial reporting. Specifically,..